The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Fedoseeva I.F.

Kemerovo State Medical University

Goncharenko A.V.

Kemerovo State Medical University

Poponnikova T.V.

Kemerovo State Medical University

Glebova I.V.

Belyaev Kuzbass Regional Clinical Hospital

Pinevich O.S.

Belyaev Kuzbass Regional Clinical Hospital

Goncharenko V.A.

Kemerovo State Medical University

Paraneoplastic opsoclonus-myoclonus syndrome

Authors:

Fedoseeva I.F., Goncharenko A.V., Poponnikova T.V., Glebova I.V., Pinevich O.S., Goncharenko V.A.

More about the authors

Read: 1079 times


To cite this article:

Fedoseeva IF, Goncharenko AV, Poponnikova TV, Glebova IV, Pinevich OS, Goncharenko VA. Paraneoplastic opsoclonus-myoclonus syndrome. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;124(12):165‑170. (In Russ.)
https://doi.org/10.17116/jnevro2024124121165

References:

  1. Bhatia P, Heim J, Cornejo P, et al. Opsoclonus-myoclonus-ataxia syndrome in children. J Neurol. 2022;269(2):750-757.  https://doi.org/10.1007/s00415-021-10536-3
  2. Yıldırım M, Öncel İ, Bektaş Ö, et al. Clinical features and outcomes of opsoclonus myoclonus ataxia syndrome. Eur J Paediatr Neurol. 2022;41:19-26.  https://doi.org/10.1016/j.ejpn.2022.09.002
  3. Kinsbourne M. Myoclonic encephalopathy of infants. J Neurol Neurosurg Psychiatry. 1962;25(3):271-276.  https://doi.org/10.1136/jnnp.25.3.271
  4. Pang KK, de Sousa C, Lang B, et al. A prospective study of the presentation and management of dancing eye syndrome/opsoclonus-myoclonus syndrome in the United Kingdom. Eur J Paediatr Neurol. 2010;14(2):156-161.  https://doi.org/10.1016/j.ejpn.2009.03.002
  5. Hasegawa S, Matsushige T, Kajimoto M, et al. A nationwide survey of opsoclonus-myoclonus syndrome in Japanese children. Brain Dev. 2015;37(7):656-660.  https://doi.org/10.1016/j.braindev.2014.10.010
  6. Pranzatelli MR, Tate ED, McGee NR. Demographic, Clinical, and Immunologic Features of 389 Children with Opsoclonus-Myoclonus Syndrome: A Cross-sectional Study. Front Neurol. 2017;8:468.  https://doi.org/10.3389/fneur.2017.00468
  7. Rossor T, Yeh EA, Khakoo Y, et al. Diagnosis and Management of Opsoclonus-Myoclonus-Ataxia Syndrome in Children: An International Perspective. Neurol Neuroimmunol Neuroinflamm. 2022;9(3):e1153. https://doi.org/10.1212/NXI.0000000000001153
  8. Segal JE, Ritchey AK, Tersak J, et al. Pediatrician’s Approach to Recognizing Neuroblastoma With Opsoclonus-Myoclonus-Ataxia Syndrome. Clin Pediatr (Phila). 2023;62(8):820-823.  https://doi.org/10.1177/00099228221147407
  9. Grossman SN, Rucker JC. Opsoclonus and ocular flutter: evaluation and management. Curr Opin Ophthalmol. 2023;34(6):465-469.  https://doi.org/10.1097/ICU.0000000000000998
  10. Yonekawa T, Saito Y, Sakuma H, et al. Augmented startle responses in opsoclonus-myoclonus syndrome. Brain Dev. 2011;33(4):335-338.  https://doi.org/10.1016/j.braindev.2010.06.005
  11. Monzani NA, Corsello A, Tagliabue C, et al. Early acute cerebellar ataxia after meningococcal B vaccine: a case report of a 7-month-old infant and a review of the literature. Ital J Pediatr. 2023;49(1):61.  https://doi.org/10.1186/s13052-023-01480-1
  12. Kachanov DYu, Shamanskaya TV, Malevich OB, Varfolomeeva SR. Opsoclonus-myoclonus syndrome and neuroblastoma (a review of literature). Russian Journal of Pediatric Hematology and Oncology. 2014;(1):62-69. (In Russ.). https://doi.org/10.17650/2311-1267-2014-0-1-62-69
  13. Cantarín-Extremera V, Jiménez-Legido M, Aguilera-Albesa S, et al. Opsoclonus-myoclonus syndrome: Clinical characteristics, therapeutic considerations, and prognostic factors in a Spanish paediatric cohort. Neurologia (Engl Ed). 2023;38(2):93-105.  https://doi.org/10.1016/j.nrleng.2020.04.030
  14. Xie S, Bai C, Li K, et al. Comparison of mediastinal and non-mediastinal neuroblastoma and ganglioneuroblastoma associated with opsoclonus-myoclonus syndrome: a systematic review and meta-analysis. Transl Cancer Res. 2022;11(10):3741-3753. https://doi.org/10.21037/tcr-22-1120
  15. Raffaghello L, Conte M, De Grandis E, et al. Immunological mechanisms in opsoclonus-myoclonus associated neuroblastoma. Eur J Paediatr Neurol. 2009;13(3):219-223.  https://doi.org/10.1016/j.ejpn.2008.04.012
  16. Du H, Cai W. Opsoclonus-myoclonus syndrome associated with neuroblastoma: Insights into antitumor immunity. Pediatr Blood Cancer. 2022;69(11):e29949. https://doi.org/10.1002/pbc.29949
  17. Saini L, Dhawan SR, Madaan P, et al. Infection-Associated Opsoclonus: A Retrospective Case Record Analysis and Review of Literature. J Child Neurol. 2020;35(7):480-484.  https://doi.org/10.1177/0883073820911327
  18. Adamaszek M, Langner S, Mehrholz J, et al. Opsoclonus-Myoclonus-Ataxia Syndrome Due to Covid-19. Cerebellum. 2024;23(3):1245-1248. https://doi.org/10.1007/s12311-023-01610-9
  19. Guedes BF, Vieira Filho MAA, Listik C, et al. HIV-associated opsoclonus-myoclonus-ataxia syndrome: early infection, immune reconstitution syndrome or secondary to other diseases? Case report and literature review. J Neurovirol. 2018;24(1):123-127.  https://doi.org/10.1007/s13365-017-0603-3
  20. Cardesa-Salzmann TM, Mora J, García Cazorla MA, et al. Epstein-Barr virus related opsoclonus-myoclonus-ataxia does not rule out the presence of occult neuroblastic tumors. Pediatr Blood Cancer. 2006;47(7):964-967.  https://doi.org/10.1002/pbc.20573
  21. Hsu M, Tejani I, Shah N, et al. Review of Opsoclonus-Myoclonus Ataxia Syndrome in Pediatric Patients. Children. 2024;11(3):367.  https://doi.org/10.3390/children11030367
  22. Chekroud AM, Anand G, Yong J, et al. Altered functional brain connectivity in children and young people with opsoclonus-myoclonus syndrome. Dev Med Child Neurol. 2017;59(1):98-104.  https://doi.org/10.1111/dmcn.13262
  23. Urtiaga Valle S, Souvannanorath S, Leboucq N, et al. Monocentric retrospective clinical outcome in a group of 13 patients with opsoclonus myoclonus syndrome, proposal of diagnostic algorithm and review of the literature. Eur J Paediatr Neurol. 2022;40:18-27.  https://doi.org/10.1016/j.ejpn.2022.07.002
  24. Sun Q, Wang Y, Xie Y, et al. Long-term neurological outcomes of children with neuroblastoma with opsoclonus-myoclonus syndrome. Transl Pediatr. 2022;11(3):368-374.  https://doi.org/10.21037/tp-21-519
  25. Malevich OB, Il’ina ES, Homyakova SP, et al. Opsoclonus–myoclonus syndrome in children with neurogenic tumors: a view of a neurologist. Pediatria. 2019;98(2):221-226.(In Russ.). https://doi.org/10.24110/0031-403X-2019-98-2-221-226
  26. Wilbur C, Yea C, Licht C, et al. An upfront immunomodulatory therapy protocol for pediatric opsoclonus-myoclonus syndrome. Pediatr Blood Cancer. 2019;66(8):e27776. https://doi.org/10.1002/pbc.27776
  27. Pranzatelli MR, Allison TJ, Tate ED. Effect of low-dose cyclophosphamide, ACTH, and IVIG combination immunotherapy on neuroinflammation in pediatric-onset OMS: A retrospective pilot study. Eur J Paediatr Neurol. 2018;22(4):586-594.  https://doi.org/10.1016/j.ejpn.2018.02.009
  28. Sakuma H, Shimizu Y, Saito Y, et al. Electrophysiological evidence of cerebral dysfunction in childhood opsoclonus-myoclonus syndrome. Mov Disord. 2010;25(7):940-945.  https://doi.org/10.1002/mds.23084
  29. Haden SV, McShane MA, Holt CM. Opsoclonus myoclonus: a non-epileptic movement disorder that may present as status epilepticus. Arch Dis Child. 2009;94(11):897-899.  https://doi.org/10.1136/adc.2009.160044
  30. Paliwal VK, Chandra S, Verma R, et al. Clonazepam responsive opsoclonus myoclonus syndrome: additional evidence in favour of fastigial nucleus disinhibition hypothesis? J Neural Transm (Vienna). 2010;117(5):613-615.  https://doi.org/10.1007/s00702-010-0366-y

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.